<DOC>
	<DOCNO>NCT00477503</DOCNO>
	<brief_summary>- Primary Objective evaluate use Ga-67 citrate alternative radiopharmaceutical CSF imaging . - Secondary Objective evaluate biodistribution , pharmacokinetics radiation dosimetry In 111 DTPA gallium-67 intrathecal injection remission leptomeningeal metastasis ( LM ) LM occurrence , remission recurrence .</brief_summary>
	<brief_title>Nuclear Imaging Human CSF Flow Using Ga-67 Citrate In-111 DTPA</brief_title>
	<detailed_description>In-111 DTPA radioactive dye standardly use check flow CSF . Ga-67 citrate use detect inflammation tumor part body , researcher want learn also able detect tumor brain spinal cord . Before enrolled study , `` screening test . '' These test help doctor decide eligible take part study . Blood ( 1-2 tablespoon ) draw routine test . This routine blood draw include pregnancy test woman able child . To eligible take part study , pregnancy test must negative . If find eligible take part study , assign 1 3 group . The group assign depend whether tumor cell find CSF last spinal fluid exam . If find cancer cell CSF earlier treatment type disease , first 5 participant assign Group A give Ga-67 citrate injection alone , baseline study . The next 5 participant cancer cell CSF earlier treatment assign Group B . Group B Ga-67 In 111 DTPA injection baseline study . Otherwise , tumor CSF treat cleared CSF , assign Group C receive standard follow-up care . At begin study , image session . This first imaging session call `` baseline '' session . For image , lie gamma camera table . Depending group , one radioactive dye inject CSF Ommaya reservoir . If Group B C , In-111 DTPA Ga-67 citrate inject 2-4 minute , total . If Group A , Ga-67 citrate alone inject 2 minute . For participant 2-17 year old , dose In-111 DTPA Ga-67 citrate adjust surface area body ( measurement body size ) . During hour immediately follow injection , head , neck , back area image ( scan ) order see CSF flow . After , scan entire body perform order see quickly radioactive dye leave different part body . These whole-body scan last 20 minute . These scan ( 1 time ) occur 1-2 , 3-4 , 6-8 , 22-24 , 28-32 , 48 , 72 hour injection . You blood sample collect injection image session order measure much radiation absorb different part brain , spine , organ . These blood sample ( less Â¼ teaspoon time ) draw whole-body scan . If Group A B , receive standard follow-up care 52 week baseline image session . This order check status disease . If cancer go remission ( tumor cell find CSF ) time 52 week , follow-up imaging session . The follow-up imaging session include procedure , In-111 DTPA and/or Ga-67 citrate injection baseline image session . If Group C , receive standard follow-up care 52 week baseline image session . If cancer reappears time 52 week , follow-up imaging session . The follow-up imaging session include procedure , In-111 DTPA Ga-67 citrate injection baseline image session . Whether Group A , B C , last follow-up imaging session , participation study . If cancer clear spinal fluid , record routine visit neuro-oncology clinic review follow progress 30 day radioisotope injection last imaging session . Researchers review medical record potential side effect . If clinical visit within week 30th day , study chair contact phone concern matter . This investigational study . In-111 DTPA commercially available FDA approve injection CSF . Although Ga-67 citrate FDA approve injection vein , FDA approve injection CSF . It commercially available , inject CSF authorize use research . Up 20 patient take part study . All enrol M. D. Anderson .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Pentetic Acid</mesh_term>
	<mesh_term>Edetic Acid</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<mesh_term>Gallium citrate</mesh_term>
	<criteria>Participants must provide informed consent . Participants must 2 year age old . Participants must know history LM establish CSF cytology . Participants must Ommaya reservoir implant least 2 day study . Participants ventriculoperitoneal shunt eligible long shunt `` open '' position image session . Participants adequate renal hepatic function . Creatinine = &lt; 1.4 mg/dL Bilirubin = &lt; 2.0 mg/dL BUN = &lt; 30 SGOT ( AST ) , alkaline phosphatase = &lt; 3 x upper norm ( Institutional norm SGOT = 756 mIU/ml alkaline phosphatase = 38126 IU/L. ) . Urine analysis within normal limit . Women child bear potential ( WOCBP ) must negative serum BHCG pregnancy test within 7 day treatment . WOCBP define postmenopausal 12 month previous surgical sterilization . Participants concurrent external beam radiation therapy brain spine plan nuclear imaging session . Participants concurrent intrathecal chemotherapy imaging session . Participants Karnofsky Performance Scale &lt; 50 Zubrod Performance Scale &gt; 2 . Participants know suspected renal hepatic disease adequately treat achieve normalize liver function test renal function test eligible criterion . Participants known history claustrophobia , establish medical record claim patient .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Central Nervous System Tumors</keyword>
	<keyword>Brain Tumors</keyword>
	<keyword>Leptomeningeal Metastasis</keyword>
	<keyword>Cerebral Spinal Fluid</keyword>
	<keyword>Human CSF Flow</keyword>
	<keyword>Nuclear Imaging</keyword>
	<keyword>Gallium-67 Citrate</keyword>
	<keyword>In-111 DTPA</keyword>
</DOC>